We also explored the relationship between inflammation and the PFS of PD‐1/PD‐L1 inhibitors based on the phenomenon that inflammation is known as the main driver of tumor development and has prognostic value in several kinds of malignant tumors.22 The gene discussed is CD274; the disease is cancer.